Enavogliflozin

DB18970InvestigationalSmall molecule

Enavogliflozin is under investigation in clinical trial NCT06399835 (Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis).

Chemical structure of Enavogliflozin
Mechanism
Curator reviewed
Formula / weight
C24H27ClO6 · 446.92 g/mol (avg)
Also known as
(1s)-1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-d-glucitol · D-glucitol, 1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-, (1s)-
Code names
DWP-16001 · ODP-9401

Resolves to

Compound
UNIIZ5MR2Y1IJJCAS1415472-28-4ChEMBLCHEMBL3703921
Clinical / RWD
ATCA10BK09
Structure
InChIKeyKORCWPOBTZTAFI-YVTYUBGGSA-NSMILES[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(C=C2)C2CC2)=C(Cl)C2=C1CCO2
Targets
P31639SLC5A2

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
26Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enavogliflozin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In